ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Para 6 of WTO Doha Delclaration: Non-Solution of TRIPS Problem

The WTO has formally adopted a solution to the defects of Article 31 of the TRIPS agreement, which stipulates that compulsory licences are predominantly for domestic use and therefore creates a peculiar situation for countries with insufficient pharmaceutical manufacturing capacity. However, the solution seems intended more to ensure that not even a single tablet of drugs produced under this system escapes into the market and less to make medicines available to countries with limited manufacturing ability.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top